Sign In
Buy SLQT
$0.747
+0.0204 (+2.81%)
At Close: Jul 31, 2026
NEW YORK, NY / ACCESS Newswire / May 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE:
SelectQuote, Inc. (SLQT) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
09:00am, Monday, 05'th May 2025
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) investors concerning the
SelectQuote to Release Fiscal Third Quarter 2025 Earnings on May 12
08:00am, Monday, 05'th May 2025
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced
NEW YORK, NY / ACCESS Newswire / May 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of SelectQuote, Inc. ("SelectQuote") (NYSE:SLQT) concerning possible violation
Bronstein, Gewirtz & Grossman, LLC Encourages SelectQuote, Inc. (SLQT) Investors to Inquire about Securities Investigation
10:00am, Sunday, 04'th May 2025
NEW YORK, NY / ACCESS Newswire / May 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE:
Shareholder Rights Advocates at Levi & Korsinsky Investigate SelectQuote, Inc. (SLQT) Regarding Possible Securities Fraud Violations
06:01pm, Saturday, 03'rd May 2025
NEW YORK, NY / ACCESS Newswire / May 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of SelectQuote, Inc. ("SelectQuote") (NYSE:SLQT) concerning possible violation
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT
10:00am, Saturday, 03'rd May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE:SLQT). Such investors are a
SelectQuote, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - SLQT
07:00pm, Friday, 02'nd May 2025
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of SelectQuote, Inc. ("SelectQuote") (NYSE:SLQT) concerning possible violation
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving SelectQuote, Inc. (NYSE: SLQT) focused on w
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT
06:15pm, Friday, 02'nd May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE:SLQT). Such investors are a
SelectQuote, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by SelectQuote (SLQT)
04:45pm, Friday, 02'nd May 2025
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of SelectQuote, Inc. ("SelectQuote") (NYSE:SLQT) concerning possible violation
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) on behalf of investors concerning t
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE:
SelectQuote: Questionable Sustainability Of Its Business Model Is Concerning
02:45pm, Tuesday, 29'th Apr 2025
SelectQuote, Inc. operates a direct-to-consumer platform for insurance and healthcare products but remains unprofitable and niche, with a market value of about $580 million. The company leverages prop
SelectQuote: Better Fundamentals Due To Medicare Advantage Reimbursement Rate Increase (Rating Upgrade)
11:26pm, Sunday, 27'th Apr 2025
I'm upgrading SelectQuote to a buy rating after the stock's recent sharp fall. The federal government recently approved a 5.06% reimbursement rate increase for Medicare Advantage plans, which should t
